Comparative Risk of Hospitalized Bleeding of <scp>P2Y12</scp> Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention

Published:2022-12-28 Issue:2 Volume:113 Page:412-422
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Kumar Arun¹^ORCID,Lutsey Pamela L.²^ORCID,St. Peter Wendy L.³^ORCID,Schommer Jon C.³^ORCID,Van't Hof Jeremy R.⁴^ORCID,Rajpurohit Abhijeet³^ORCID,Farley Joel F.³^ORCID

Affiliation:

1. Department of Pharmacy Practice & Administrative Sciences James L. Winkle College of Pharmacy, University of Cincinnati Cincinnati Ohio USA

2. Division of Epidemiology and Community Health School of Public Health, University of Minnesota Minneapolis Minnesota USA

3. Department of Pharmaceutical Care and Health Systems College of Pharmacy, University of Minnesota Minneapolis Minnesota USA

4. Cardiovascular Division and Lillehei Heart Institute University of Minnesota Medical School Minneapolis Minnesota USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2806

Reference30 articles.

1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

2. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

4. Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study

5. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome;Journal of Thrombosis and Thrombolysis;2024-03-31

2. Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013–2018;Clinical and Translational Science;2023-08-03

3. Bleeding risk greater with prasugrel versus clopidogrel and ticagrelor;Reactions Weekly;2022-12-10